Study Stopped
Original principal investigator left the institution and investigator replacing him did not have the patient population to enroll as needed.
Effect of NSAID Use on Pain and Opioid Consumption Following Distal Radius Fracture
Adult NSAID
1 other identifier
interventional
32
1 country
1
Brief Summary
Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are excellent medications for providing pain control in certain patients. There is some data to suggest that NSAIDs can be used to reduce postoperative pain and narcotic use in patients who had undergone carpal tunnel release. There are mixed results about the effect of bone healing in adult patients with broken bones. The investigators hypothesize that NSAID administration in the acute phase of distal radius fracture healing will be non-inferior for pain control and decrease the use of opioid analgesics compared to patients who take acetaminophen for pain control during this same time period. Furthermore, the investigators hypothesize that patients will have similar or better patient reported outcomes, range of motion, and strength with the administration of NSAIDs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Jan 2019
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2018
CompletedFirst Posted
Study publicly available on registry
November 21, 2018
CompletedStudy Start
First participant enrolled
January 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 24, 2022
CompletedResults Posted
Study results publicly available
September 5, 2024
CompletedSeptember 5, 2024
August 1, 2024
3.2 years
September 26, 2018
December 18, 2023
August 14, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Number of Oxycodone Tablets Used for Breakthrough Pain.
The number and dosing of oxycodone tablets taken per participant for breakthrough pain will be recorded.
2 weeks
Intensity of Pain: Visual Analog Scale (VAS)
The patient will be asked to report their pain on a scale of 0 - 10 using the Visual Analog Scale with 0 being no pain and 10 being the worst pain the patient can imagine.
2 Week, 6 Week, 3 Month, 6 Month and 1 Year Post Surgery
Fractures Fully Healed
Radiographic evidence of boney healing of the distal radius. This outcome measure is reported as the number of participants in each group with fully healed fractures at the designated time point.
6 weeks post surgery
Secondary Outcomes (5)
QuickDASH
2 Week, 6 Week, 3 Month, 6 Month and 1 Year Post Surgery
Patient Reported Outcomes Measurement Information System (PROMIS) - UE (Upper Extremity)
2 Weeks, 6 Weeks, 3 Months, 6 Months and 1 Year post surgery
Grip Strength
2 Week, 6 Week and 3 Month Post Surgery
Key Pinch Strength
2 weeks, 6 weeks, and 3 months post surgery
Wrist Range of Motion (ROM)
2 weeks, 6 weeks and 3 months post surgery
Study Arms (2)
Acetaminophen
ACTIVE COMPARATORAcetaminophen for pain control with dose and frequency of 325mg 1-2 tablets q4-6h hours as needed, Maximum dose 1000mg. Maximum amount per day: 3g/day. Oxycodone 5mg 1-2 tablets q4-6 hours will be available as needed for breakthrough pain.
NSAID
EXPERIMENTALNSAID administered ibuprofen 400-800 mg, up to three times a day and acetaminophen with dose and frequency of 325mg 1-2 tablets q4-6h hours as needed, Maximum dose 1000mg. Maximum amount per day: 3g/day as needed for pain control. Oxycodone 5mg 1-2 tablets q4-6 hours will be available for breakthrough pain.
Interventions
NSAID Group - will be administered ibuprofen 400-800 mg, up to three times a day as needed for pain control
Control Group - will be administered acetaminophen for pain control with dose and frequency of 325mg 1-2 tablets q4-6h hours as needed, Maximum dose 1000mg. Maximum amount per day: 3g/day.
Eligibility Criteria
You may qualify if:
- Age ≥ 18
- Distal radius fracture
You may not qualify if:
- Contraindication to NSAID use (ie, cannot tolerate, gastritis, ulcers, chronic kidney disease stage 4 or higher, bleeding disorders/thrombocytopenia)
- Inability to take breakthrough medications
- Regular use of NSAIDs
- Regular use of Narcotics
- Open fracture
- Other orthopaedic injuries (polytrauma)
- Pathologic fracture
- Previous injury to the bone
- Pregnant or plan to become pregnant
- Unable to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri Health Care
Columbia, Missouri, 65212, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Vicki L Jones
- Organization
- UMissouri
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel A London, MD
University of Missouri-Columbia
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Orthopedic Surgery
Study Record Dates
First Submitted
September 26, 2018
First Posted
November 21, 2018
Study Start
January 2, 2019
Primary Completion
March 24, 2022
Study Completion
March 24, 2022
Last Updated
September 5, 2024
Results First Posted
September 5, 2024
Record last verified: 2024-08